Oncology product facilities
Beacon Pharmaceuticals PLC is the first pharmaceutical manufacturer that developed oncology facility in Bangladesh. Beacon Oncology facility is the symbol of highly innovative technology and skillful expertise. Beacon introduced lyophilization technology for the first time in Bangladesh.
- Currently, along with conventional chemotherapies, oral targeted therapies, and immunotherapies/monoclonal antibodies are also manufactured in this facility.
- This facility is producing a number of global brands like Tagrix, Lenvanix, Elbonix, Pembroxim, Nivolunix etc.
Treating Cancer with State-of-the-Art Technology
Highlight the latest technology and specialized facilities dedicated to producing oncology medications. Describe how these facilities adhere to stringent quality standards and regulatory guidelines, ensuring the creation of cutting-edge treatments for various types of cancer. BEACON installed state of the art technologies in its dedicated Oncology manufacturing plant.
Comprehensive Oncology Portfolio
Emphasize the breadth of oncology products developed and manufactured within these facilities. Discuss how BEACON Pharmaceuticals' commitment to cancer care is realized through a diverse range of therapies, including targeted therapies, immunotherapies, and other innovative solutions tailored to combat different forms of cancer.
